Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy

Three cardinal manifestations of neoplasia, namely inflammation, immune dysfunction, and coagulopathy are also seen in patients with severe SARS-CoV-2 infection, providing a biological rationale for testing selected anticancer drugs for their ability to control the symptoms and/or modify the course...

Descripción completa

Detalles Bibliográficos
Autores principales: Saini, Kamal S., Lanza, Carlo, Romano, Marco, de Azambuja, Evandro, Cortes, Javier, de las Heras, Begoña, de Castro, Javier, Lamba Saini, Monika, Loibl, Sibylle, Curigliano, Giuseppe, Twelves, Chris, Leone, Manuela, Patnaik, Mrinal M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307309/
https://www.ncbi.nlm.nih.gov/pubmed/32572174
http://dx.doi.org/10.1038/s41416-020-0948-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307309/
https://www.ncbi.nlm.nih.gov/pubmed/32572174
http://dx.doi.org/10.1038/s41416-020-0948-x

Ejemplares similares